COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,883 Articles (22,568 medRxiv, 8,315 bioRxiv)

Most recent first Previous |  Page 1613: Articles 16121-16130  | Next

Predictive modeling of COVID-19 New Confirmed Cases in Algeria using Artificial Neural Network
Djeddou, M., Hameed, I. A., Hellal, A., Nejatian, A.
10.1101/2021.03.29.21254532 — Posted: 2021-04-04
Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an Emergency Department
Nguyen Van, J.-C., Gerlier, C., Pilmis, B., Mizrahi, A., Pean de Ponfilly, G., khaterchi, A., Enouf, V., Ganansia, O., Le Monnier, A.
10.1101/2021.03.29.21253909 — Posted: 2021-04-04
RELATIONSHIP OF LIVER ENZYME LEVELS WITH THE CLINICAL COURSE OF COVID-19
ince, u., duran, h. t.
10.1101/2021.03.29.21254559 — Posted: 2021-04-04
Clinical efficacy of Early Administration of Convalescent Plasma among COVID-19 Cases in Egypt
Asem, N., Massoud, H. H., Serag, E., Hassany, M., ElAssal, G., Abdelbary, A., Mohsen, M., Abdelbary, A., Zaky, S., Amin, W., Kamal, E., Ibrahem, H., Mohsen, A. S., Aly, M. A., Elgendy, N., Elbadry, M., Ahmed, S. H., Shenouda, N. N., Fathy, M. A., Zaid, H.
10.1101/2021.03.30.21254031 — Posted: 2021-04-04
Determining the cutoff points of the 5C scale for assessment of COVID-19 vaccines psychological antecedents among the Arab population: A multinational study
Ghazy, R., Abd ElHafeez, S., Shaban, R., Elbarazi, I., Abdou, M. S., Ramadan, A. M., Kheirallah, K. A.
10.1101/2021.03.27.21254461 — Posted: 2021-04-04
Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model
Dhakal, S., Ruiz-Bedoya, C. A., Zhou, R., Creisher, P., Villano, J., Littlefield, K., Castillo, J., Marinho, P., Jedlicka, A., Ordonez, A., Majewska, N., Betenbaugh, M., Flavahan, K., Mueller, A., Looney, M., Quijada, D., Mota, F., Beck, S. E., Brockhurst, J. K., Braxton, A., Castell, N., D'Alessio, F., Metcalf Pate, K. A., Karakousis, P. C., Mankowski, J. L., Pekosz, A., Jain, S. K., Klein, S. L.
10.1101/2021.04.02.438292 — Posted: 2021-04-04
Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies
Lempp, F. A., Soriaga, L., Montiel-Ruiz, M., Benigni, F., Noack, J., Park, Y.-J., Bianchi, S., Walls, A. C., Bowen, J. E., Zhou, J., Kaiser, H., Agostini, M., Meury, M., Dellota, E., Jaconi, S., Cameroni, E., Virgin, H. W., Lanzavecchia, A., Veesler, D., Purcell, L., Telenti, A., Corti, D.
10.1101/2021.04.03.438258 — Posted: 2021-04-04
Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques
Hasenkrug, K. J., Feldmann, F., Myers, L., Santiago, M. L., Guo, K., Barrett, B. S., Mickens, K. L., Carmody, A., Okumura, A., Rao, D., Collins, M. M., Messer, R. J., Lovaglio, J., Shaia, C., Rosenke, R., van Doremalen, N., Clancy, C., Saturday, G., Hanley, P., Smith, B., Meade-White, K., Shupert, W. L., Hawman, D. W., Feldmann, H.
10.1101/2021.04.02.438262 — Posted: 2021-04-04
Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
Moeller, N. H., Shi, K., Demir, O., Banerjee, S., Yin, L., Belica, C., Durfee, C., Amaro, R. E., Aihara, H.
10.1101/2021.04.02.438274 — Posted: 2021-04-04
Background rates of hospitalizations and emergency department visits for selected thromboembolic and coagulation disorders in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
Nasreen, S., Calzavara, A., Sundaram, M., MacDonald, S. E., Righolt, C., Pai, M., Field, T., Zhou, L. W., Wilson, S., Kwong, J.
10.1101/2021.04.02.21254856 — Posted: 2021-04-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).